Intensity Therapeutics, Inc. INTS
NASDAQ · United States · Health Technology
$3.44+0.23 (+7.17%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -1.11 | -0.87 | -27.2% | $0 | — | -3.0%$4.29→$4.16 |
| Q1 2026 | 2026-05-07 | -0.96 | -1.35 | +28.9% | — | — | -2.3%$5.21→$5.09 |
| Q4 2024 | 2025-03-13 | -5.50 | -5.60 | +1.8% | — | — | — |
| Q4 2023 | 2024-03-14 | -3.00 | -4.50 | +33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.